Gene expression `signature' limitations and genome architecture-based perspectives for robust cancer biomarkers

Author： Katsios Christos S   Papaloukas Costas   Roukos Dimitrios H   Baltogiannis George  

Publisher： Future Medicine

ISSN： 1752-0363

Source： Biomarkers in Medicine, Vol.7, Iss.1, 2013-02, pp. : 79-82

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Integrating expression‐related SNPs into genome‐wide gene‐ and pathway‐based analyses identified novel lung cancer susceptibility genes

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 8, 2018-04 ,pp. : 1602-1610 (9)

John Wiley & Sons Inc

Access to resources Recommend Favorite

Robust depth-based tools for the analysis of gene expression data

By Lpez-Pintado Sara   Romo Juan   Torrente Aurora  

Biostatistics, Vol. 11, Iss. 2, 2010-04 ,pp. : 254-264 (11)

Oxford University Press

Access to resources Recommend Favorite

Gene Expression Profiles of Non-Small Cell Lung Cancer: Survival Prediction and New Biomarkers

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 283-292 (10)

Karger

Access to resources Recommend Favorite

Urinary biomarkers of bladder cancer: an update and future perspectives

By Rosser Charles J   Urquidi Virginia   Goodison Steve  

Biomarkers in Medicine, Vol. 7, Iss. 5, 2013-10 ,pp. : 779-790 (12)

Future Medicine

Access to resources Recommend Favorite

Performance characteristics of the MammaPrint® breast cancer diagnostic gene signature

By Delahaye Leonie JM   Wehkamp Diederik   Floore Arno N   Bernards Rene   van‘t Veer Laura J   Glas Annuska M  

Personalized Medicine, Vol. 10, Iss. 8, 2013-11 ,pp. : 801-811 (11)

Future Medicine

Access to resources Recommend Favorite